SEC Form 4 · accession 0001127602-15-015679
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Clackson
Officer — President, R&D, CSO
Period of report
Apr 29, 2015
Accepted (ET)
Apr 30, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Apr 29, 2015 | A | 70,200 | A | — | — | Common Stock | 70,200 | 70,200 | D |
Explanation of responses
- F1Restricted stock units vest as to 33-1/3% of the award on each of April 29, 2016, April 29, 2017 and April 29, 2018.
- F2N/A